Massive Bio Partners with TOUCH, The Black Breast Cancer Alliance and Navigating Trials to Expand Cancer Patients' Access to Clinical Trials
AI-powered trial matching now available through two trusted cancer advocacy and navigation platforms
Massive Bio, a global precision oncology company, today announced a new partnership with TOUCH, The Black Breast Cancer Alliance (TOUCH BBCA), a breast cancer patient advocacy organization, and Navigating Trials, a clinical trial navigation platform serving patients across all cancer types. Through this collaboration, Massive Bio's AI-powered trial matching will be made available directly within both organizations' digital platforms, giving their patient communities a seamless, no-cost pathway to personalized clinical trial options.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260529101109/en/ Massive Bio is partnering with TOUCH, The Black Breast Cancer Alliance, and Navigating Trials to break down barriers and expand access to clinical trials for cancer patients.
TOUCH BBCA supports breast cancer patients through education, advocacy, and access to resources. Navigating Trials extends the reach of clinical research to patients across all cancer indications, helping individuals find and navigate trial opportunities that match their specific situation. Both organizations provide 24/7 navigation with navigators who have lived experience with the disease state. Together, the two organizations form a connected network that meets patients where they already are.
